NPPA panel fixes retail price of Zuventus antihypertensive FDC Efonidipine, telmisartan, details
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg manufactured and marketed by Zuventus Healthcare.The retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for...
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg manufactured and marketed by Zuventus Healthcare.
The retail price of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare has been set at Rs 15.67 per tablet excluding GST
The recommendation came during the 39th meeting of the Multidisciplinary Committee of Experts held on February 25,2022, under the convenorship of Shri Manmohan Sachdeva, Advisor (Cost), through video-conferencing.
The issue of retail price fixation of uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare Ltd under Para 5 of DPCO 2013 was analysed at the meeting.
Fixed-dosed combination regimen consisting of a Efonidipine Hydrochloride Ethanolate and Telmisartan represent a new addition to the available antihypertensive treatment options. This combination has a better efficacy, defined by time to reach blood pressure targets as well as levels of blood pressure achieved, compared with the individual drugs. The combination is well tolerated, including in patients with stage 2 hypertension and the elderly.
After detailed deliberation, the committee recommended that the retail price of each uncoated bilayered tablet containing Efonidipine hydrochloride ethanolate 20mg and telmisartan IP 40mg for Zuventus Healthcare at Rs 15.67 per tablet excluding GST as detailed below.
Computation of Retail Price per Tablet | Source/ Method | |
Composition-Each uncoated bilayered tablet containing Efonidipine Hydrochloride Ethanolate 40 mg + Telmisartan IP 40 mg | ||
a.Efonidipine Hydrochloride Ethanolate 40 mg(Calculated as per Para 4 of DPCO 2013) | Retail price(as per June,2021 data) | 10.38 |
B. Telmisartan IP 40 mg | Ceiling Price(as per notification no .1330€ dated 25th March,2021. | 6.61 |
Worked out Retail Price(a+b) | 16.99 | |
c.Less 20% of the lowest of (a) and (b) as recommended win the pronab Sen Committee report | 1.32 | |
Net Retail Price (a+b+c) (per tablet excluding GST) | 15.67 | |
Company Claimed Price excluding GST (per tablet) | 19.20 | |
Recommended price excluding GST (per tablet) | 15.67 |
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd